Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications
Not Applicable
Completed
- Conditions
- SarcomaSolid Tumor GastrointestinalLung
- Registration Number
- NCT02833246
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Brief Summary
This study is being done to determine if sending reminder text messages helps patients take their Oral Anticancer Medication (OAMs) when they are supposed to.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
- Patient in the Sarcoma, Solid Tumor Gastrointestinal (ST GI), and Thoracic Medicine service at MSK.
- Starting a new treatment regimen that includes a single oral anticancer medication
- Patients must have a mobile phone that can send and receive SMS/MMS messages and is internet-enabled.
- Age 18 or older.
- Ability to speak and read English because we do not have the resources to translate the text messages into other languages.
Exclusion Criteria
- Patient expresses inability or unfamiliarity with using SMS/MMS messaging on their phone and is unwilling to be trained in the use of this technology.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method objective pill count 1 year is greater or less than the amount of OAM that the patient should have in their possession.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie improved adherence to OAMs via SMS/MMS interventions in sarcoma and lung cancer patients?
How does SMS-based adherence monitoring compare to traditional methods in managing solid tumor gastrointestinal and lung malignancies?
Are there specific biomarkers associated with better response to mHealth interventions for OAM adherence in metastatic sarcoma?
What adverse events are commonly reported with SMS/MMS adherence strategies in cancer patients receiving oral chemotherapy?
How do SMS/MMS interventions for OAM adherence in NCT02833246 compare to other digital health tools like mobile apps or wearable devices?
Trial Locations
- Locations (1)
Memorial Sloan Kettering Cancer Center
🇺🇸New York, New York, United States
Memorial Sloan Kettering Cancer Center🇺🇸New York, New York, United States